Investigating the role of the I–II linker in Nav1.5 channel function
- 4 September 2025
- journal article
- Published by Rockefeller University Press in Journal of General Physiology
- Vol. 157 (6)
Abstract
The cardiac voltage-gated sodium channel, Nav1.5, initiates the cardiac action potential. Its dysfunction can lead to dangerous arrhythmias, sudden cardiac arrest, and death. The functional Nav1.5 core consists of four homologous repeats (I, II, III, and IV), each formed from a voltage sensing and a pore domain. The channel also contains three cytoplasmic linkers (I–II, II–III, and III–IV). While Nav1.5 structures have been published, the I–II and II–III linkers have remained absent, are predicted to be disordered, and their functional role is not well understood. We divided the I–II linker into eight regions ranging in size from 32 to 52 residues, chosen based on their distinct properties. Since these regions had unique sequence properties, we hypothesized that they may have distinct effects on channel function. We tested this hypothesis with experiments with individual Nav1.5 constructs with each region deleted. These deletions had small effects on channel gating, though two (430–457del and 556–607del) reduced peak current. Phylogenetic analysis of the I–II linker revealed five prolines (P627, P628, P637, P640, and P648) that were conserved in mammals but absent from the Xenopus sequence. We created mutant channels, where these were replaced with their Xenopus counterparts. The only mutation that had a significant effect on channel gating was P627S, which depolarized channel activation (10.13 ± 2.28 mV). Neither a phosphosilent (P627A) nor a phosphomimetic (P627E) mutation had a significant effect, suggesting that either phosphorylation or another specific serine property is required. Since deletion of large regions had little effect on channel gating while a point mutation had a conspicuous impact, the I–II linker role may be to facilitate interactions with other proteins. Variants may have a larger impact if they create or disrupt these interactions, which may be key in evaluating the pathogenicity of variants.Keywords
Funding Information
- National Heart Lung and Blood Institute
- National Institutes of Health (R01 HL148803)
This publication has 73 references indexed in Scilit:
- Frequency of Irritable Bowel Syndrome in Patients with Brugada Syndrome and Drug-Induced Type 1 Brugada PatternThe American Journal of Cardiology, 2021
- Structural Basis for Pore Blockade of the Human Cardiac Sodium Channel Nav1.5 by the Antiarrhythmic Drug Quinidine**Angewandte Chemie International Edition, 2021
- Voltage-Gated Sodium Channel β Subunits and Their Related Diseases2017
- Interplay between R513 methylation and S516 phosphorylation of the cardiac voltage-gated sodium channelAmino Acids, 2014
- Cardiac Sodium Channel Nav1.5 Mutations and Cardiac ArrhythmiaPediatric Cardiology, 2012
- Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testingHeart Rhythm, 2005
- Channel Activation Voltage Alone Is Directly Altered in an Isoform-specific Manner by Na v1.4 and Na v1.5 Cytoplasmic LinkersThe Journal of Membrane Biology, 2004
- A Novel mutation L619F in the cardiac Na channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gatingHuman Mutation, 2003
- Influence of proline residues on protein conformationJournal of Molecular Biology, 1991
- A simple method for displaying the hydropathic character of a proteinJournal of Molecular Biology, 1982